BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 16285891)

  • 1. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
    Chen W; Ford MS; Young KJ; Zhang L
    Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
    Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
    Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells.
    Voelkl S; Gary R; Mackensen A
    Eur J Immunol; 2011 Mar; 41(3):739-48. PubMed ID: 21287552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
    Zhang HG; Su X; Liu D; Liu W; Yang P; Wang Z; Edwards CK; Bluethmann H; Mountz JD; Zhou T
    J Immunol; 1999 Feb; 162(3):1423-30. PubMed ID: 9973398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
    Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
    Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation.
    Ma Y; He KM; Garcia B; Min W; Jevnikar A; Zhang ZX
    Xenotransplantation; 2008 Feb; 15(1):56-63. PubMed ID: 18333914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.
    Zhang ZX; Yang L; Young KJ; DuTemple B; Zhang L
    Nat Med; 2000 Jul; 6(7):782-9. PubMed ID: 10888927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation.
    McIver Z; Serio B; Dunbar A; O'Keefe CL; Powers J; Wlodarski M; Jin T; Sobecks R; Bolwell B; Maciejewski JP
    Br J Haematol; 2008 Apr; 141(2):170-8. PubMed ID: 18318770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
    Wang RF
    Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of Treg cells in defective tumor immunity.
    Kosmaczewska A; Ciszak L; Potoczek S; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):181-91. PubMed ID: 18512029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
    Shevach EM
    Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the T cell response.
    Romagnani S
    Clin Exp Allergy; 2006 Nov; 36(11):1357-66. PubMed ID: 17083345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.